Vigil Neuroscience, Inc. (VIGL)
NASDAQ: VIGL · Real-Time Price · USD
1.910
+0.020 (1.06%)
At close: Mar 28, 2025, 4:00 PM
1.904
-0.006 (-0.29%)
After-hours: Mar 28, 2025, 6:00 PM EDT
Vigil Neuroscience Market Cap
Vigil Neuroscience has a market cap or net worth of $89.14 million as of March 28, 2025. Its market cap has decreased by -14.32% in one year.
Market Cap
89.14M
Enterprise Value
4.29M
1-Year Change
-14.32%
Ranking
Category
Stock Price
$1.91
Market Cap Chart
Since the IPO on January 7, 2022, Vigil Neuroscience's market cap has decreased from $395.70M to $89.14M, a decrease of -77.47%. That is a compound annual growth rate of -37.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 89.14M | 28.41% |
| Dec 31, 2024 | 69.42M | -42.76% |
| Dec 29, 2023 | 121.27M | -72.73% |
| Dec 30, 2022 | 444.76M | 12.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |